PT Kalbe Farma Tbk.
PTKFY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.20 | -1.10 | 0.54 | 0.43 |
| FCF Yield | 1.28% | 1.27% | 0.32% | 1.29% |
| EV / EBITDA | 46.02 | 46.73 | 35.98 | 59.26 |
| Quality | ||||
| ROIC | 2.45% | 3.20% | 4.06% | 3.19% |
| Gross Margin | 38.10% | 40.68% | 41.56% | 41.01% |
| Cash Conversion Ratio | 1.38 | – | 0.32 | – |
| Growth | ||||
| Revenue 3-Year CAGR | -5.64% | 3.35% | 3.59% | 4.09% |
| Free Cash Flow Growth | -99.99% | 334.53% | -81.25% | 12.13% |
| Safety | ||||
| Net Debt / EBITDA | -3.22 | -2.33 | -2.63 | -3.40 |
| Interest Coverage | 60.08 | 101.20 | 146.32 | 70.39 |
| Efficiency | ||||
| Inventory Turnover | 0.78 | 0.71 | 0.79 | 0.76 |
| Cash Conversion Cycle | 137.96 | 151.60 | 139.71 | 137.61 |